Behcet

Beh·çet

(be-shet'),
Hulusi, Turkish dermatologist, 1889-1948. See: Behçet disease, Behçet syndrome.
References in periodicals archive ?
Uysal et al., "A double-blind trial of depot corticosteroids in Behcet's syndrome," Rheumatology, vol.
M2 PRESSWIRE-September 2, 2019-: Behcet's Disease Therapeutics Market - Global Forecast and Analysis 2019-2023
With this third indication in the U.S., OTEZLA is the first and only treatment approved for oral ulcers associated with Behcet's Disease
The US Food and Drug Administration has granted approval to United States-based Celgene for its Otezla (apremilast) 30mg twice daily, intended to treat adult patients with oral ulcers associated with Behcet's Disease, it was reported yesterday that.
After a work-up, the girl's ulcers were found to be a symptom not of herpes but of a rare disorder known as Behcet's syndrome or Behcet's disease.
Behcet's syndrome is considered as a syndrome because of its diverse clinical expressions.
Behcet's disease is a multisystemic condition of unknown etiology characterized by chronic, recurrent vasculitis.
Behcet's disease (BD) is an inflammatory disorder of unknown etiology, characterized by recurrent aphthous stomatitis, genital ulceration, and uveitis triad.
The patient had been diagnosed with Behcet's disease (BD) 3 years before admission to our hospital, suffered from deep venous thrombosis related to BD, and was being treated with prednisolone.
Behcet's disease (BD) is a multisystem relapsing vasculitis of unknown etiology.
Behcet's Disease (BD) is a inflammatory disease of unclear etiology characterized by three associated symptoms including attacks of ocular lesions, oral aphthous ulcers, and genital sores, (Sakane et al., 1999).
Behcet's disease (BD) is a systemic vasculitis of small and large vessels.